Table 1 |
||
|
Patient characteristics |
||
|
Osteoarthritis |
Rheumatoid arthritis |
|
|
|
||
|
Number |
10 |
7 |
|
Age (years) |
62.8 ± 3.2 |
57.0 ± 4.0 |
|
Sex (f/m) |
6/4 |
4/3 |
|
C-reactive protein (mg/L) |
5.1 ± 1.3 |
25.9 ± 14.1# |
|
Erythrocyte sedimentation rate (mm) |
11.5 ± 1.5 |
27.6 ± 3.1* |
|
Lining layer thickness, cells |
2.0 ± 0.5 |
2.5 ± 0.2 |
|
Cellular density (all cells), cells/mm2 |
364 ± 169 |
635 ± 329 |
|
T-cell density, cells/mm2 |
1.1 ± 0.1 |
1.9 ± 0.5 |
|
Macrophage density, cells/mm2 |
55 ± 38 |
52 ± 16 |
|
Medication |
||
|
Prednisolone (%) |
N.A. |
86.0 |
|
Daily prednisolone (mg/day) |
N.A. |
6.1 ± 1.7 |
|
Methotrexate (%) |
N.A. |
71.0 |
|
Leflunomide (%) |
N.A. |
14.0 |
|
Nonsteroidal antiinflammatory drugs (%) |
70.0 |
71.0 |
|
|
||
|
Data are given as mean ± SEM. *P < 0.05; #P < 0.005 for the comparison with osteoarthritis. Abbreviations: N.A., not applicable. |
||
|
Riepl et al. Arthritis Research & Therapy 2010 12:R110 doi:10.1186/ar3044 |
||
